These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12384391)

  • 21. Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.
    García-Sureda L; Juan C; Doménech-Sánchez A; Albertí S
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1803-5. PubMed ID: 21282437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.
    García-Sureda L; Doménech-Sánchez A; Barbier M; Juan C; Gascó J; Albertí S
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4742-7. PubMed ID: 21807980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo selection of porin-deficient mutants of Klebsiella pneumoniae with increased resistance to cefoxitin and expanded-spectrum-cephalosporins.
    Martínez-Martínez L; Hernández-Allés S; Albertí S; Tomás JM; Benedi VJ; Jacoby GA
    Antimicrob Agents Chemother; 1996 Feb; 40(2):342-8. PubMed ID: 8834877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Joshi P; Shrivastava R; Bhagwat S; Patel M
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Pichardo C; del Carmen Conejo M; Bernabéu-Wittel M; Pascual A; Jiménez-Mejías ME; de Cueto M; Pachón-Ibáñez ME; García I; Pachón J; Martínez-Martínez L
    Clin Microbiol Infect; 2005 Jan; 11(1):31-8. PubMed ID: 15649301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
    Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
    Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emergence of carbapenem resistance due to porin loss in an extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae strain during meropenem therapy.
    Webster DP; Gaulton T; Woodford N; Pike R; Turton J; Perry C; Bowler IC
    Int J Antimicrob Agents; 2010 Dec; 36(6):575-6. PubMed ID: 20869852
    [No Abstract]   [Full Text] [Related]  

  • 29. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.
    Poirel L; Héritier C; Tolün V; Nordmann P
    Antimicrob Agents Chemother; 2004 Jan; 48(1):15-22. PubMed ID: 14693513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outer membrane protein alterations and blaTEM-1 variants: their role in beta-lactam resistance in Klebsiella pneumoniae.
    Nelson EC; Segal H; Elisha BG
    J Antimicrob Chemother; 2003 Dec; 52(6):899-903. PubMed ID: 14613957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
    J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.
    Tsai YK; Fung CP; Lin JC; Chen JH; Chang FY; Chen TL; Siu LK
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1485-93. PubMed ID: 21282452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the Genetic Background of KPC-2-Producing
    Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM
    Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance.
    Doménech-Sánchez A; Martínez-Martínez L; Hernández-Allés S; del Carmen Conejo M; Pascual A; Tomás JM; Albertí S; Benedí VJ
    Antimicrob Agents Chemother; 2003 Oct; 47(10):3332-5. PubMed ID: 14506051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18.
    Rasheed JK; Anderson GJ; Yigit H; Queenan AM; Doménech-Sánchez A; Swenson JM; Biddle JW; Ferraro MJ; Jacoby GA; Tenover FC
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2382-8. PubMed ID: 10952583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An ertapenem-resistant extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant.
    García-Fernández A; Miriagou V; Papagiannitsis CC; Giordano A; Venditti M; Mancini C; Carattoli A
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4178-84. PubMed ID: 20660683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
    Mena A; Plasencia V; García L; Hidalgo O; Ayestarán JI; Alberti S; Borrell N; Pérez JL; Oliver A
    J Clin Microbiol; 2006 Aug; 44(8):2831-7. PubMed ID: 16891499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.